Advertisement

Internal Medicine

Home Internal Medicine
Smoking increases the risk that Crohn's disease patients will experience clinical recurrence after bowel surgery

Smokers More Prone to Relapse After Crohn’s Surgery

Research supports mercaptopurine for smokers, but not for nonsmokers

August 2016 Briefing – Internal Medicine

Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for August 2016. This roundup includes the...
For patients with non-insulin-treated type 2 diabetes

Δ9-Tetrahydrocannabivarin Beneficial in Type 2 Diabetes

THCV significantly decreases fasting plasma glucose, improves pancreatic β-cell function
Factors that are associated with exacerbation-prone asthma have been identified

Comorbidity Factors Identified for Exacerbation-Prone Asthma

Blood eosinophils, BMI, bronchodilator responsiveness tied to exacerbation frequency
Much of the weight lost via bariatric surgery appears to stay off for at least 10 years

Long-Term Follow-Up Shows Bariatric Patients Keep Weight Off

10-year follow-up study finds many who had gastric bypass surgery maintained weight loss
Dysbiosis from unexpected environmental sources is seen within days after intensive care unit admission

Healthy Gut Microbiome Compromised in ICU Patients

Increased levels of harmful bacteria boost the risk for hospital-acquired infections, researchers say
As perceptions of marijuana change

Number of U.S. Adults Using Marijuana Up Significantly

Daily use nearly doubled between 2002 and 2014; fewer people perceive drug as harmful
Various smartphone apps can help patients adopt a healthy lifestyle that might reduce risk of cardiovascular events

Phone Apps Help Patients Reach Health, Fitness Goals

Smartphones can motivate patients to stay on track with lifestyle changes
A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration.

FDA Approves Biosimilar Drug Erelzi for Rheumatoid Arthritis

Erelzi is a biosimilar for Enbrel; treats RA and other inflammatory diseases
For patients with ST-segment elevation myocardial infarction

Off-Hours Presentation Not Detrimental in STEMI

Time of PCI did not affect STEMI efficacy or safety outcomes in large international trial